Background illustration for clinical trials search

Paid Clinical Trials Tacoma

Discover 1,461 paid clinical trials in Tacoma, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others

for
Charcot Marie Tooth Disease
Location: Seattle WA, Palo Alto CA, Los Angeles CA, Aurora CO,
Sponsor: Michael Shy

Sex: All

Age: 0+

Code: NCT01193075

Recruiting
Active & Responsive

PLAT-08: A Study Of SC-DARIC33 CAR T Cells In Pediatric And Young Adults With Relapsed Or Refractory CD33+ AML

for
Acute Myeloid Leukemia, Acute Myeloid Leukemia Refractory,
Location: Seattle WA
Sponsor: Seattle Children's Hospital

Sex: All

Age: 0 - 30

Code: NCT05105152

Phase 1, Recruiting
Active & Responsive

A Study of DB-OTO, an Adeno-Associated Virus (AAV) Based Gene Therapy, in Children/Infants, Adolescents and Adults With Hearing Loss Due to Otoferlin Mutations

for
Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF),
Location: Seattle WA, Los Angeles CA, San Diego CA, Milwaukee WI,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 0+

Code: NCT05788536

Phase 1, Phase 2, Recruiting
Active & Responsive

Advancing Transplantation Outcomes in Children

for
Kidney Transplant
Location: Seattle WA, Vancouver, Los Angeles CA, Aurora CO,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 13 - 20

Code: NCT06055608

Phase 2, Recruiting
Active & Responsive

Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial

for
Pneumonia, Urinary Tract Infections, Soft Tissue Infections,
Location: Seattle WA, Mountain View CA, Palo Alto CA,
Sponsor: University of Utah

Sex: All

Age: 0 - 18

Code: NCT05471908

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes

for
Type 1 Diabetes, Diabetic Kidney Disease,
Location: Seattle WA
Sponsor: Kalie Tommerdahl

Sex: All

Age: 12 - 25

Code: NCT05065372

Phase 1, Recruiting
Active & Responsive

Outcomes in Pediatric and Young Adult B-Cell Malignancies After Commercially Available Immunotherapy

for
Lymphoid Leukemia
Location: Seattle WA, Portland OR, San Francisco CA, Palo Alto CA,
Sponsor: Stanford University

Sex: All

Age: 0 - 26

Code: NCT05865301

Recruiting
Active & Responsive

Slow Heart Registry of Fetal Immune-mediated High Degree Heart Block

for
Heart Block Complete, Heart Block Second Degree
Location: Seattle WA, San Francisco CA, Denver CO, Phoenix AZ,
Sponsor: The Hospital for Sick Children

Sex: Female

Age: 16 - 50

Code: NCT04559425

Recruiting
Active & Responsive

Hemoglobin Maintenance in Pediatric ESRD (End-stage Renal Disease) Patients by Ferric Pyrophosphate Citrate (FPC)

for
End Stage Renal Disease
Location: Seattle WA, Loma Linda CA, Kansas City MO,
Sponsor: Rockwell Medical Technologies, Inc.

Sex: All

Age: 0 - 17

Code: NCT04239391

Phase 3, Recruiting
Active & Responsive

Long-Term Follow-Up of Subjects Treated With Seattle Children's Therapeutics Gene Therapy Products

for
CAR T Cell, CAR T Cell Therapy
Location: Seattle WA
Sponsor: Seattle Children's Hospital

Sex: All

Age: 0+

Code: NCT07424157

Recruiting
Active & Responsive

A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

for
Type 1 Diabetes, New Onset
Location: Seattle WA, San Francisco CA, Minneapolis MN,
Sponsor: City of Hope Medical Center

Sex: All

Age: 9 - 20

Code: NCT07061574

Phase 1, Phase 2, Recruiting
Active & Responsive

EPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)

for
PIK3CA-related Overgrowth Spectrum (PROS)
Location: Seattle WA, Portland OR, Sacramento CA, St Louis MO,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 2 - 70+

Code: NCT06997588

Phase 2, Recruiting
Active & Responsive

Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)

for
Cystic Fibrosis
Location: Seattle WA, Denver CO, Aurora CO, Kansas City KS,
Sponsor: Boston Children's Hospital

Sex: All

Age: 6+

Code: NCT06683092

Recruiting
Active & Responsive

Effects of High-Resistance Inspiratory Muscle Strength Training on Cardiorenal and Vascular Function in Youth and Young Adults With Type 2 Diabetes

for
Diabetes Mellitus Type 2
Location: Seattle WA
Sponsor: Seattle Children's Hospital

Sex: All

Age: 14 - 40

Code: NCT06936670

Recruiting
Active & Responsive

High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients

for
Immunization; Infection, Transplantation Infection, Influenza
Location: Seattle WA, Stanford CA, Kansas City MO, Chicago IL,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 3 - 17

Code: NCT05947071

Phase 2, Recruiting
Active & Responsive

Fontan Udenafil Exercise Longitudinal Assessment Trial - 2

for
Single Ventricle Heart Disease
Location: Seattle WA, San Francisco CA, Salt Lake City UT,
Sponsor: Mezzion Pharma Co. Ltd

Sex: All

Age: 12 - 18

Code: NCT05918211

Phase 3, Recruiting
Active & Responsive

Tirzepatide in PWS, HO and GNSO

for
Prader-Willi Syndrome, Hypothalamic Obesity, Obesity/Therapy
Location: Seattle WA, Saint Paul MN, Nashville TN
Sponsor: Grace Kim

Sex: All

Age: 18 - 26

Code: NCT06901245

Recruiting
Active & Responsive

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

for
Parenteral Nutrition Associated Liver Disease (PNALD),
Location: Seattle WA, Los Angeles CA, Fountain Valley CA,
Sponsor: Fresenius Kabi

Sex: All

Age: 0 - 17

Code: NCT06274788

Recruiting
Active & Responsive

A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)

for
PIK3CA-Related Overgrowth Spectrum (PROS),
Location: Seattle WA, San Francisco CA, Palo Alto CA,
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 2+

Code: NCT06789913

Phase 2, Recruiting
Active & Responsive

Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders

for
Turner Syndrome, Short Stature Homeobox Gene Mutation,
Location: Seattle WA, Idaho Falls ID, Sacramento CA, Palo Alto CA,
Sponsor: Ascendis Pharma A/S

Sex: All

Age: 2 - 17

Code: NCT07221851

Phase 3, Recruiting